• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

第二代 H1 抗组胺药在特殊情况下的应用。

Use of second generation H1 antihistamines in special situations.

出版信息

J Investig Allergol Clin Immunol. 2013;23 Suppl 1:1-16.

PMID:24672890
Abstract

Antihistamine drugs are one of the therapeutic classes most used at world level, at all ages and in multiple situations. Although in general they have a good safety profile, only the more recent drugs (second generation antihistamines) have been studied specifically with regard to the more important safety aspects. Given the variety of antihistamine drugs, they cannot all be considered equivalent in application to various special clinical situations, so that the documented clinical experience must be assessed in each case or, in the absence of such, the particular pharmacological characteristics of each molecule for the purpose of recommendation in these special situations. In general, there are few clinical studies published for groups of patients with kidney or liver failure, with concomitant multiple pathologies (such as cardiac pathology), in extremes of age (paediatrics or geriatrics) and in natural stages such as pregnancy or lactation, but these are normal situations and it is more and more frequent (among the elderly) for antihistamine drugs to be recommended. This review sets out the more relevant details compiled on the use of antihistamines in these special situations.

摘要

抗组胺药物是全球范围内使用最广泛的治疗类别之一,适用于各个年龄段和多种情况。尽管它们通常具有良好的安全性,但只有最近开发的药物(第二代抗组胺药)才针对更重要的安全性方面进行了专门研究。鉴于抗组胺药物种类繁多,它们在各种特殊临床情况下的应用不能一概而论,因此必须根据具体情况评估有记录的临床经验,或者在缺乏这种经验的情况下,根据每个分子的特殊药理学特性来推荐这些特殊情况下的使用。一般来说,在患有肾衰竭或肝功能衰竭、伴有多种合并症(如心脏病理学)、年龄极端(儿科或老年科)以及妊娠或哺乳期等自然阶段的患者群体中,很少有发表的临床研究,但这些都是正常情况,在老年人中,越来越频繁地推荐使用抗组胺药物。本综述列出了在这些特殊情况下使用抗组胺药物的更相关详细信息。

相似文献

1
Use of second generation H1 antihistamines in special situations.第二代 H1 抗组胺药在特殊情况下的应用。
J Investig Allergol Clin Immunol. 2013;23 Suppl 1:1-16.
2
Pharmacological rationale for the treatment of chronic urticaria with second-generation non-sedating antihistamines at higher-than-standard doses.用高于标准剂量的第二代非镇静抗组胺药治疗慢性荨麻疹的药理学原理。
J Eur Acad Dermatol Venereol. 2012 Jan;26(1):9-18. doi: 10.1111/j.1468-3083.2011.04185.x. Epub 2011 Jul 29.
3
New oral H1 antihistamines in children: facts and unmeet needs.儿童新型口服H1抗组胺药:现状与未满足的需求
Allergy. 2008 Oct;63(10):1395-404. doi: 10.1111/j.1398-9995.2008.01771.x.
4
Use of antihistamines in pediatrics.抗组胺药在儿科的应用。
J Investig Allergol Clin Immunol. 2007;17 Suppl 2:28-40.
5
Bilastine: a new antihistamine with an optimal benefit-to-risk ratio for safety during driving.比拉斯汀:一种新型抗组胺药,在驾驶时安全性方面具有最佳的效益风险比。
Expert Opin Drug Saf. 2016 Jan;15(1):89-98. doi: 10.1517/14740338.2016.1112786. Epub 2015 Nov 16.
6
Antihistamines in the treatment of chronic urticaria.抗组胺药治疗慢性荨麻疹
J Investig Allergol Clin Immunol. 2007;17 Suppl 2:41-52.
7
Safety evaluation of desloratadine in allergic rhinitis.地氯雷他定治疗变应性鼻炎的安全性评价。
Expert Opin Drug Saf. 2013 May;12(3):445-53. doi: 10.1517/14740338.2013.788148. Epub 2013 Apr 11.
8
Assessment of antihistamines in the treatment of skin allergies.抗组胺药治疗皮肤过敏的评估。
Curr Opin Allergy Clin Immunol. 2011 Oct;11(5):428-37. doi: 10.1097/ACI.0b013e32834a96e9.
9
Levocetirizine for the treatment of allergic rhinitis and chronic idiopathic urticaria in adults and children.左西替利嗪用于治疗成人和儿童的过敏性鼻炎及慢性特发性荨麻疹。
Clin Ther. 2009 Aug;31(8):1664-87. doi: 10.1016/j.clinthera.2009.08.015.
10
Second-generation antihistamines for the treatment of chronic idiopathic urticaria.用于治疗慢性特发性荨麻疹的第二代抗组胺药。
J Drugs Dermatol. 2010 May;9(5):503-12.

引用本文的文献

1
The efficacy of topical cetirizine using microneedling in androgenetic alopecia male patients.微针给药局部使用西替利嗪治疗男性雄激素性脱发的疗效。
Arch Dermatol Res. 2025 Apr 1;317(1):665. doi: 10.1007/s00403-025-04108-y.
2
Diagnosis and Management of Urticaria in Indian Settings: Skin Allergy Research Society's Guideline-2022.印度环境下荨麻疹的诊断与管理:皮肤过敏研究学会2022年指南
Indian J Dermatol. 2022 Nov-Dec;67(6):732-743. doi: 10.4103/ijd.ijd_307_22.
3
Chronic Urticaria in Older Adults: Treatment Considerations.老年慢性荨麻疹:治疗考量
Drugs Aging. 2023 Mar;40(3):165-177. doi: 10.1007/s40266-023-01010-y. Epub 2023 Feb 18.
4
Prevalence, Clinical Manifestations, Treatment, and Clinical Course of Chronic Urticaria in Elderly: A Systematic Review.老年人慢性荨麻疹的患病率、临床表现、治疗及临床病程:一项系统评价
J Asthma Allergy. 2022 Oct 20;15:1455-1490. doi: 10.2147/JAA.S379912. eCollection 2022.
5
Clinical Guidelines for the Use of Antipruritic Drugs in the Control of the Most Frequent Pruritic Skin Diseases in Dogs.犬类常见瘙痒性皮肤病防治中止痒药物使用的临床指南
Vet Sci. 2022 Mar 22;9(4):149. doi: 10.3390/vetsci9040149.
6
Turkish Guideline for Diagnosis and Treatment of Allergic Rhinitis (ART).土耳其变应性鼻炎诊断与治疗指南(ART)
Turk Arch Otorhinolaryngol. 2021 May;59(Suppl 1):1-157. doi: 10.4274/tao.2021.suppl.1.
7
Sensitisation patterns and allergy outcomes in pregnant women living in the urban area.城市地区孕妇的致敏模式和过敏结局
Allergy Asthma Clin Immunol. 2021 May 10;17(1):46. doi: 10.1186/s13223-021-00547-0.
8
Using Patient Profiles To Guide The Choice Of Antihistamines In The Primary Care Setting In Malaysia: Expert Consensus And Recommendations.利用患者档案指导马来西亚基层医疗环境中抗组胺药的选择:专家共识与建议
Ther Clin Risk Manag. 2019 Oct 31;15:1267-1275. doi: 10.2147/TCRM.S221059. eCollection 2019.
9
A Review of the Ingredients Contained in Over the Counter (OTC) Cough Syrup Formulations in Kenya. Are They Harmful to Infants?肯尼亚非处方(OTC)止咳糖浆制剂所含成分综述。它们对婴儿有害吗?
PLoS One. 2015 Nov 5;10(11):e0142092. doi: 10.1371/journal.pone.0142092. eCollection 2015.
10
Management of chronic spontaneous urticaria in the elderly.老年人慢性自发性荨麻疹的管理
Drugs Aging. 2015 Apr;32(4):271-82. doi: 10.1007/s40266-015-0249-x.